|
ERBB4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.5237001377576E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.61459973063916E-10 |
| Normal-vs-Stage2 |
1.24820043190255E-10 |
| Normal-vs-Stage3 |
1.25039978371433E-10 |
| Normal-vs-Stage4 |
1.17949983113874E-10 |
| Stage1-vs-Stage2 |
1.717830E-01 |
| Stage1-vs-Stage3 |
6.054000E-02 |
| Stage1-vs-Stage4 |
1.026790E-01 |
| Stage2-vs-Stage3 |
7.814400E-01 |
| Stage2-vs-Stage4 |
9.018800E-01 |
| Stage3-vs-Stage4 |
8.484000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64619984310832E-10 |
| Normal-vs-AfricanAmerican |
1.32839961253239E-10 |
| Normal-vs-Asian |
7.18060055859837E-11 |
| Caucasian-vs-AfricanAmerican |
6.294500E-02 |
| Caucasian-vs-Asian |
1.196550E-03 |
| AfricanAmerican-vs-Asian |
1.918140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6421997095506E-10 |
| Normal-vs-Female |
5.75310021844189E-10 |
| Male-vs-Female |
1.105000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.81950043709867E-10 |
| Normal-vs-Extreme_Weight |
1.51009982296557E-10 |
| Normal-vs-Obese |
3.39450023645327E-10 |
| Normal-vs-Extreme_Obese |
4.9569999993615E-08 |
| Normal_Weight-vs-Extreme_Weight |
2.139200E-01 |
| Normal_Weight-vs-Obese |
7.340000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.073200E-01 |
| Extreme_Weight-vs-Obese |
1.498020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.293600E-01 |
| Obese-vs-Extreme_Obese |
9.290600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.09629971767333E-10 |
| Normal-vs-Age(41-60Yrs) |
2.75929945559028E-10 |
| Normal-vs-Age(61-80Yrs) |
2.26139995618269E-10 |
| Normal-vs-Age(81-100Yrs) |
1.12890030656843E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.380200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.876980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.400600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.002000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.095600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.280100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.12480025293848E-10 |
| Normal-VS-Type2 PRCC |
8.62310223226359E-13 |
| Normal-VS-KIRP CIMP |
1.4875001230763E-10 |
| Normal-VS-Unclassified PRCC |
1.42289957594244E-10 |
| Type1 PRCC-VS-Type2 PRCC |
6.502000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.438200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.032400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.766990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.267010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.804200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09189990382674E-10 |
| Normal-vs-N1 |
1.75339964769705E-10 |
| Normal-vs-N2 |
2.522300E-02 |
| N0-vs-N1 |
1.457650E-01 |
| N0-vs-N2 |
4.190600E-01 |
| N1-vs-N2 |
4.634000E-01 |
|
|
